Fiera Capital (Canada)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,265
Closed -$447K – 466
2024
Q2
$447K Sell
3,265
-1,700
-34% -$233K ﹤0.01% 392
2024
Q1
$661K Sell
4,965
-85
-2% -$11K ﹤0.01% 377
2023
Q4
$696K Buy
+5,050
New +$664K ﹤0.01% 407
2023
Q1
– Sell
-8,934
Closed -$1.4M – 503
2022
Q4
$1.4M Sell
8,934
-806
-8% -$116K ﹤0.01% 325
2022
Q3
$1.19M Buy
9,740
+85
+0.9% +$11.2K ﹤0.01% 358
2022
Q2
$1.28M Buy
9,655
+5,510
+133% +$751K ﹤0.01% 367
2022
Q1
$568K Buy
4,145
+1,341
+48% +$187K ﹤0.01% 510
2021
Q4
$486K Buy
2,804
+311
+12% +$47.3K ﹤0.01% 530
2021
Q3
$362K Buy
2,493
+42
+2% +$6.14K ﹤0.01% 511
2021
Q2
$323K Buy
2,451
+2
+0.1% +$262 ﹤0.01% 545
2021
Q1
$314K Sell
2,449
-337
-12% -$41.5K ﹤0.01% 538
2020
Q4
$332K Buy
2,786
+3
+0.1% +$366 ﹤0.01% 583
2020
Q3
$319K Buy
2,783
+274
+11% +$32.4K ﹤0.01% 535
2020
Q2
$286K Sell
2,509
-21,549
-90% -$2.29M ﹤0.01% 553
2020
Q1
$1.93M Buy
24,058
+21,953
+1,043% +$2.27M 0.01% 321
2019
Q4
$225K Buy
2,105
+47
+2% +$4.9K ﹤0.01% 627
2019
Q3
$220K Buy
+2,058
New +$211K ﹤0.01% 608
2018
Q2
– Sell
-2,149
Closed -$216K – 700
2018
Q1
$216K Buy
+2,149
New +$220K ﹤0.01% 614
2017
Q3
– Sell
-2,736
Closed -$304K – 669
2017
Q2
$304K Buy
+2,736
New +$289K ﹤0.01% 575

Other funds holding DGX

Fiera Capital (Canada)'s DGX Position: Q3 2024 in Review

Fiera Capital (Canada) sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 3,265 shares — an estimated $447K sold.

Fiera Capital (Canada) first reported a position in DGX in Q2 2017 and held it in 19 quarters. The position peaked at $1.93M in Q1 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Fiera Capital (Canada) reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Fiera Capital (Canada) sold 3,265 Quest Diagnostics shares in Q3 2024, an estimated $447K.
  • Fiera Capital (Canada) first reported a position in Quest Diagnostics in Q2 2017 and held it in 19 quarters.
  • Fiera Capital (Canada)'s Quest Diagnostics position peaked at $1.93M in Q1 2020.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2024, filed 1 Nov 2024.